transmiss
gastroenter
viru
tgev
etiolog
agent
transmiss
gastroenter
tge
highli
contagi
enter
diseas
piglet
caus
high
mortal
rate
result
especi
sever
econom
loss
affect
farm
membran
protein
one
structur
protein
tgev
two
phosphoryl
nucleoprotein
n
spike
protein
lipid
envelop
protein
highli
glycosyl
help
viral
nucleocapsid
bind
capsul
membran
protein
tgev
expos
carboxytermin
region
extern
surfac
virion
proteinspecif
monoclon
antibodi
use
neutral
tgev
mediat
tgevinfect
cellular
complementdepend
lysi
suggest
protein
good
immunogen
reactogen
tgev
protein
affect
mutat
viru
confin
endoplasm
reticulum
viru
assembl
multifunct
protein
crucial
role
coronaviru
assembl
could
interact
membran
protein
e
protein
time
ctermin
domain
integr
within
viral
core
drive
coronaviru
compon
earli
studi
suggest
tgevinfect
piglet
blood
gut
high
level
interferon
ifn
confirm
induct
interferon
relat
interact
protein
cell
membran
proteinspecif
monoclon
antibodi
effect
block
synthesi
n
protein
could
show
induct
interferon
region
locat
outsid
protein
play
major
effector
role
three
structur
protein
n
express
baculoviru
intraperiton
inocul
pig
result
show
protein
induc
intestin
mucos
immun
concern
iga
antibodi
tgev
confirm
increas
occurr
doubleposit
cell
dim
natur
killer
bright
cytotox
tcell
phenotyp
accompani
increas
express
receptor
find
indic
gene
could
use
potenti
target
gene
develop
genet
vaccin
recent
year
attenu
salmonella
typhimurium
typhimurium
util
carrier
like
intracellular
bacteria
shigella
listeria
effici
deliveri
either
dna
vaccin
vaccin
antigen
oral
immun
live
vaccin
vector
attenu
typhimurium
weak
virul
good
invas
meanwhil
bacteria
carri
heterolog
antigen
oral
immun
present
host
immun
system
induc
antispecif
antigen
local
system
immun
respons
particular
attenu
typhimurium
use
deliv
dna
vaccin
encod
immunogen
pathogen
microorgan
includ
hiv
prrsv
previou
studi
reveal
attenu
typhimurium
good
carrier
tgev
gene
howev
use
typhimurium
dna
vaccin
vector
harbor
tgev
gene
almost
report
studi
investig
feasibl
oral
vaccin
base
tgev
gene
construct
dna
vaccin
encod
intact
tgev
glycoprotein
use
attenu
intracellular
bacteria
attenu
typhimurium
safeti
immunogen
evalu
preliminari
data
indic
immun
orogastr
intub
recombin
typhimurium
could
induc
specif
immun
respons
tgev
swine
testicl
st
cell
human
embryon
kidney
cell
cultur
dulbecco
modifi
eagl
medium
dmem
high
glucos
invitrogen
supplement
fetal
bovin
serum
fb
invitrogen
solut
invitrogen
cell
maintain
eukaryot
express
vector
store
laboratori
tgev
strain
sch
isol
sichuan
pr
china
attenu
typhimurium
aroastrain
kindli
provid
professor
kai
schulz
helmholtz
centr
infect
research
germani
femal
balbc
mice
week
old
g
use
throughout
studi
purchas
chengdu
dossi
biolog
technolog
compani
chengdu
china
anim
maintain
anim
hold
laboratori
control
condit
temperatur
humid
given
free
access
food
water
mice
receiv
human
care
accord
usa
nation
institut
health
guid
care
use
laboratori
anim
viral
rna
extract
tgevinfect
st
cell
use
beij
tiangen
total
rna
extract
kit
approxim
kb
dna
fragment
includ
open
read
frame
glycoprotein
amplifi
viru
genom
rna
rtpcr
follow
primer
pair
forward
revers
respect
introduc
xba
restrict
site
end
primer
amplifi
dna
fragment
tgev
gene
clone
vector
takara
sequenc
target
fragment
releas
plasmid
xbai
noti
digest
ligat
vector
digest
enzym
final
plasmid
name
pvaxm
cell
seed
sixwel
tissu
cultur
plate
costar
monolay
confluent
cell
transient
transfect
plasmid
pvaxm
empti
plasmid
use
lipofectamin
invitrogen
h
post
transfect
part
cell
collect
verifi
rtpcr
anoth
part
cell
wash
phosphatebuff
salin
pb
fix
icecold
methanolaceton
min
wash
pb
dilut
antiserum
pig
tgev
store
laboratori
secondari
antibodi
fitcconjug
rabbit
antipig
igg
sigma
incub
sequenti
h
rest
cell
collect
cell
lysi
buffer
ad
obtain
protein
sampl
target
protein
transfer
polyvinyliden
difluorid
pvdf
membran
sdspage
first
antibodi
swine
tgev
posit
serum
dilut
tbst
second
antibodi
hrpgoatantipig
antibodi
dilut
tbst
incub
success
construct
plasmid
pvaxm
control
vector
transform
typhimurium
compet
cell
electropor
kv
ms
posit
transform
select
lb
agar
contain
kanamycin
detect
pcr
amplif
digest
restrict
enzym
result
typhimurium
strain
name
strain
pvaxm
strain
pvax
respect
recombin
strain
pvaxm
dilut
ml
lb
liquid
medium
contain
kanamycin
ml
lb
kanamycinfre
liquid
medium
respect
bacteria
cultur
contain
plasmid
differ
condit
without
kanamycin
taken
appropri
dilut
respect
h
dilut
appli
three
kanamycinfre
lb
plate
three
lb
plate
contain
kanamycin
h
cultur
coloni
plate
coloni
count
flat
accord
averag
number
coloni
plate
kanamycin
lb
averag
number
coloni
kanamycinfre
lb
plate
calcul
resist
stabil
pressur
recombin
plasmid
salmonella
nonresist
pressur
cultur
condit
fiveweekold
mice
inocul
intragastr
cfu
pvaxm
control
mice
given
dosag
pvax
three
day
immun
payer
patch
remov
three
mice
pool
cellular
rna
isol
homogen
payer
patch
beij
tiangen
total
rna
extract
kit
accord
manufactur
instruct
rtpcr
use
amplifi
fulllength
tgev
gene
primer
pair
previous
describ
typhimurium
strain
pvaxm
cultur
describ
previous
bacteri
cell
collect
overnight
growth
centrifug
min
pellet
resuspend
pb
contain
sodium
bicarbon
mv
three
group
balbc
mice
consist
eighteen
mice
inocul
intragastr
use
gavag
needl
pvaxm
dosag
cfu
boost
dosag
week
later
immun
mice
monitor
daili
clinic
chang
day
three
mice
group
sacrif
collect
spleen
liver
everi
week
postimmun
organ
homogen
ml
pb
contain
triton
vv
bacteri
count
determin
plate
spleen
liver
homogen
lb
agar
plate
contain
kanamycin
overnight
incub
enumer
colonyform
unit
bacteri
coloni
pick
randomli
pcr
evalu
tgev
gene
digest
restrict
enzym
fiveweekold
balbc
mice
randomli
divid
three
group
fifteen
mice
group
immun
three
time
interv
mice
depriv
food
water
h
immun
mice
group
b
inocul
intragastr
pvaxm
control
strain
pvax
dosag
cfu
per
mous
group
c
mice
receiv
pb
neg
control
three
mice
group
sacrif
sera
complet
intestin
lavag
collect
week
primari
immun
blood
obtain
submaxillari
sinu
mice
sera
obtain
centrifug
blood
serum
sampl
store
aliquot
prior
experi
prepar
intestin
fluid
whole
small
intestin
remov
mous
excess
fat
remov
cut
piec
wash
ml
pb
contain
phenylmethylsulfonylfluorid
pmsf
sampl
centrifug
min
remov
cellular
debri
supernat
freezedri
use
freez
dryer
dissolv
ml
pb
contain
pmsf
centrifug
min
supernat
collect
final
intestin
lavag
store
prior
analysi
serum
igg
intestin
iga
determin
elisa
polystyren
microtitr
plate
costar
coat
overnight
purifi
tgev
antigen
carbon
buffer
ph
block
h
pb
contain
bsa
wv
plate
wash
three
time
pb
contain
tween
pbst
incub
dilut
mice
serum
intestin
lavag
sampl
h
wash
three
time
pbst
hrpconjug
goat
antimic
igg
iga
sigma
dilut
use
secondari
antibodi
incub
h
benzidin
tmb
employ
chromogen
substrat
reaction
stop
min
incub
dark
addit
room
temperatur
optic
densiti
measur
spectrophotometr
nm
cytokin
detect
mous
interleukin
elisa
kit
mous
interferon
elisa
kit
respect
step
follow
kit
data
mean
sd
three
independ
experi
perform
triplic
result
analyz
student
test
p
valu
less
consid
statist
signific
approxim
kb
dna
fragment
amplifi
rtpcr
tgev
sch
strain
basic
consist
expect
length
gene
sequenc
analysi
show
amplifi
tgev
sch
strain
gene
fragment
bp
length
contain
gene
open
read
frame
bp
encod
amino
acid
result
sequenc
align
show
predict
amino
acid
sequenc
tgve
sch
strain
gene
fragment
share
homolog
sequenc
tgev
purdu
strain
result
show
gene
fragment
success
incorpor
vector
restrict
analysi
pcr
fig
transfect
hek
cell
gene
detect
rtpcr
fig
confirm
plasmid
pvaxm
eventu
transfect
hek
cell
line
seventytwo
hour
infect
express
tgev
protein
detect
via
indirect
immunofluoresc
assay
cytofluores
observ
hek
cell
transfect
pvaxm
fig
pvax
fig
western
blot
assay
specif
strip
kda
observ
express
product
pvaxm
total
tgevposit
serum
suggest
eukaryot
plasmid
pvaxm
could
express
protein
cell
fig
pvaxm
appli
lb
solid
medium
contain
kanamycin
free
kanamycin
coloni
coloni
plate
count
calcul
recombin
attenu
salmonella
two
differ
time
point
medium
carri
plasmid
stabil
result
show
condit
without
antibiot
recombin
attenu
salmonella
plasmid
recombin
bacteria
prolifer
rapidli
lost
indic
recombin
plasmid
absenc
antibiot
stabl
enough
condit
antibiot
recombin
attenu
salmonella
plasmid
h
cultur
stabl
enough
fig
safeti
analysi
femal
balbc
mice
inocul
oral
recombin
pvaxm
differ
dosag
clinic
aberr
observ
observ
period
except
lassitud
first
day
gavag
kinet
bacteria
colon
persist
vivo
investig
bacteria
isol
liver
spleen
differ
dosag
group
week
postinocul
experi
suggest
eventu
elimin
liver
spleen
week
postinocul
fig
pcr
result
reveal
constant
presenc
gene
recov
bacteri
isol
fig
abil
recombin
typhimurium
induc
mucos
immun
respons
determin
measur
level
iga
antibodi
tgev
intestin
lavag
sampl
shown
fig
recombin
typhimurium
induc
detect
iga
antibodi
tgev
mice
rapidli
week
postvaccin
consider
enhanc
antibodi
titer
could
observ
group
receiv
pvaxm
dosag
cfu
week
postimmun
antibodi
level
group
much
higher
pvax
group
group
b
p
significantli
greater
pb
group
group
c
p
week
second
immun
antibodi
level
group
significantli
higher
group
b
c
p
abil
recombin
typhimurium
induc
humor
immun
respons
determin
measur
level
igg
antibodi
tgev
serum
sampl
shown
fig
none
group
detect
antibodi
respons
week
postvaccin
mice
group
receiv
pvaxm
dosag
cfu
show
differ
level
antibodi
respons
experi
week
postimmun
antibodi
titer
gener
group
reach
peak
detect
specif
antitgev
antibodi
pvax
group
group
b
pb
group
group
c
experi
standard
curv
plot
accord
usa
r
system
mous
detect
kit
respect
standard
detect
result
regress
equat
r
regress
equat
standard
curv
r
result
calcul
use
curv
equat
concentr
sampl
content
chang
map
shown
fig
induc
recombin
pvaxm
detect
week
higher
pvax
control
group
p
pb
control
group
p
maximum
amount
immun
group
detect
week
content
signific
differ
p
two
control
group
figur
indic
content
pvaxm
increas
significantli
week
maxim
week
decreas
week
entir
procedur
immun
immun
pvaxm
group
perform
significantli
better
p
pvax
pb
control
group
data
indic
oral
vaccin
pvaxm
could
induc
bodi
cellular
immun
respons
effect
mice
tge
import
viral
diseas
infect
intestin
mucosa
secretori
iga
siga
induc
resist
infect
viru
intestin
mucosa
igg
igm
provid
littl
protect
virus
thu
effect
stimul
mucos
immun
system
obtain
mucos
immun
respons
import
implic
prevent
treatment
tge
current
research
mainli
focu
tgev
n
gene
studi
gene
express
tgev
gene
eukaryot
system
first
time
studi
tgev
sch
strain
gene
length
bp
success
amplifi
rtpcr
includ
sequenc
open
read
frame
encod
amino
acid
gene
also
detect
rtpcr
protein
detect
western
bolt
indirect
immunofluoresc
assay
eukaryot
express
plasmid
pvaxm
transfect
hek
cell
aid
foundat
followup
research
new
develop
focus
product
deliveri
protein
oral
immun
sever
system
use
express
fulllength
truncat
tgev
protein
salmonella
lactobacillu
casei
plant
howev
express
level
antigen
protein
transgen
plant
gener
low
lose
bioactiv
due
degrad
stomach
acid
live
bacteri
vector
offer
mani
potenti
clinic
advantag
stabl
easi
rel
inexpens
mass
product
also
abl
deliv
multipl
antigen
oral
deliveri
increas
safeti
eas
administr
addit
bacteria
natur
possess
immunostimulatori
molecul
lipopolysaccharid
lp
function
adjuv
stimul
immun
respons
furthermor
live
bacteri
vector
abl
induc
system
immun
respons
includ
humor
cellular
mucos
immun
pathogen
infect
previou
studi
shown
express
tgev
gene
deliv
attenu
typhimurium
detect
mous
periton
macrophag
vitro
transcript
gene
payer
patch
vivo
studi
construct
attenu
typhimurium
harbor
tgev
gene
method
detect
express
gene
mous
termin
ileum
suggest
attenu
typhimurium
pvaxm
practic
util
oral
deliveri
vector
tgev
dna
vaccin
plasmid
pass
bodi
success
stabl
express
antigen
gene
extrem
import
oral
vaccin
use
attenu
salmonella
relat
whether
could
constantli
effect
stimul
bodi
produc
immun
respons
studi
affirm
stabil
plasmid
might
relev
plasmid
copi
number
ovalbumin
express
attenu
salmonella
harbor
lowcopi
number
plasmid
could
stimul
produc
specif
antiovalbumin
ctl
reaction
carri
highcopi
number
plasmid
order
enhanc
plasmid
stabil
immun
antibiot
inject
mice
period
immun
yet
result
reveal
practic
get
plasmid
enhanc
vivo
method
studi
stabil
recombin
attenu
salmonella
vaccin
pvaxm
vivo
vitro
detect
result
show
bacteria
reduc
nearli
without
kanamycin
resist
stabil
test
vitro
h
observ
safeti
studi
neither
death
side
effect
found
mice
postinocul
attenu
typhimurium
pvaxm
differ
dosag
cfu
bacteria
recov
liver
spleen
differ
dosag
group
week
boost
indic
attenu
typhimurium
could
elimin
immun
system
complet
plasmid
deliveri
time
notic
one
week
boost
bacteria
separ
liver
spleen
differ
dosag
group
significantli
lower
week
first
inocul
indic
elimin
immun
system
bacteri
enhanc
increas
inocul
frequenc
week
first
immun
recombin
attenu
salmonella
final
elimin
bodi
thu
indic
strain
pvaxm
could
exist
steadili
result
indic
use
attenu
typhimurium
ideal
choic
deliveri
vector
dna
vaccin
oral
concern
safeti
livestock
data
show
attenu
typhimurium
pvaxm
rel
good
safeti
bodi
attenu
typhimurium
induc
siga
due
colon
specif
mucos
surfac
intern
organ
advantag
attenu
natur
propag
restrict
vivo
view
tgev
pathogenesi
livestock
infect
viru
digest
tract
difficult
bodi
gain
protect
igg
antibodi
therefor
gutspecif
siga
antibodi
produc
mammalian
mucos
immun
protect
signific
studi
oral
immun
construct
dna
vaccin
contain
attenu
typhimurium
pvaxm
specif
serum
antibodi
detect
week
continu
week
appear
significantli
compar
pvax
group
pb
group
level
igg
iga
antibodi
peak
level
week
gradual
decreas
week
last
week
detect
use
mice
anim
model
experi
conduct
studi
show
level
antibodi
igg
iga
immun
pvaxm
higher
immun
pvax
consist
previou
result
attenu
typhimurium
harbor
tgev
gene
detect
cytokin
content
often
use
import
indic
reflect
mous
cellular
immunolog
respons
addit
repres
cytokin
secret
thl
cell
cytokin
secret
cell
yang
found
respons
stimul
mice
inocul
oral
attenu
typhimurium
contain
surfac
protein
leishmania
discov
sestak
also
found
significantli
increas
express
mononuclear
cell
mesenter
lymph
node
stimul
inactiv
tgev
antigen
vitro
decreas
phenotyp
studi
content
anim
bodi
also
significantli
improv
pvaxm
significantli
higher
pvax
pb
group
present
studi
certain
limit
vaccin
good
immun
effect
mous
model
may
produc
immun
stimul
effect
pig
moreov
challeng
protect
test
evalu
effect
new
vaccin
essenti
test
conduct
speci
mice
studi
construct
pvaxm
gene
tgev
safeti
immunogen
preliminarili
assess
use
mice
anim
model
tgev
easili
infect
clinic
neonat
swine
day
prone
diarrhea
stress
condit
attenu
salmonella
test
result
indic
releas
carri
dna
vaccin
mice
induc
humor
immun
mucos
immun
cellular
immun
respons
previou
studi
zhang
immun
piglet
pvaxn
oral
vaccin
serum
first
collect
detect
igg
iga
week
postimmun
result
claim
experi
group
pvaxn
improv
significantli
contrast
control
group
p
even
vaccin
zhang
induc
good
immun
respons
howev
best
time
pedv
infect
pass
piglet
howev
mous
model
advantag
reduc
cost
test
requir
smaller
cultur
space
shorten
period
immun
respons
balbc
mice
immun
dose
formul
administ
cattl
evalu
immunogen
inactiv
vaccin
foodandmouth
diseas
viru
specif
antibodi
detect
day
postimmun
show
adequ
immun
respons
vaccin
immun
dose
day
psot
immun
deng
found
could
replic
mice
caus
mice
tissu
damag
similar
tissu
damag
caus
pig
indic
mice
could
use
anim
model
research
vaccin
gravier
studi
claim
dna
vaccin
similar
biodistribut
mous
rabbit
pig
tissu
vivo
studi
focu
effect
evalu
oral
vaccin
pregnant
sow
design
immun
pvaxn
oral
vaccin
piglet
within
day
age
chosen
perform
challeng
assay
neutral
assay
